Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2
The previous Special Issue of the Journal of Clinical Medicine, ‘Integrating Clinical and Translational Research Networks—Building Team Medicine’, which highlighted our collective experience from the City of Hope and was published in 2020, was a huge success. Buoyed by the enthusiastic response from...
Saved in:
| Format: | Online |
|---|---|
| Sprog: | engelsk |
| Udgivet: |
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
| Fag: | |
| Online adgang: | ONIX_20230911_9783036584720_51 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
| _version_ | 1869526770853609472 |
|---|---|
| collection | Directory of Open Access Books |
| description | The previous Special Issue of the Journal of Clinical Medicine, ‘Integrating Clinical and Translational Research Networks—Building Team Medicine’, which highlighted our collective experience from the City of Hope and was published in 2020, was a huge success. Buoyed by the enthusiastic response from our peers and colleagues, we have embarked on bringing out Volume 2. The basic theme is the same—namely, integrating academic medical centers with the clinical network in various geographic locations to ensure that all patients, regardless of their physical proximity to major medical institutions, can benefit from recent clinical advances. As in the previous volume on the importance of including basic research scientists, our aim here is to highlight translational research approaches that leverage the combined knowledge, skills, experience, expertise, and vision of clinicians in academic medical centers, their affiliated community centers, and hospitals, together with those of basic research scientists. However, here we also strive to include bioinformaticians and data scientists. We look forward to sharing our team medicine experience with our colleagues around the world and trust that they will find the approach described in the articles included in this Special issue useful for guiding their approaches for treating cancer patients. |
| format | Online |
| id | doab-20.500.12854ir-113918 |
| institution | Directory of Open Access Books |
| language | eng |
| publishDate | 2023 |
| publishDateRange | 2023 |
| publishDateSort | 2023 |
| publisher | MDPI - Multidisciplinary Digital Publishing Institute |
| publisherStr | MDPI - Multidisciplinary Digital Publishing Institute |
| record_format | ojs |
| spelling | doab-20.500.12854ir-1139182024-03-31T13:10:43Z Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2 Salgia, Ravi Kulkarni, Prakash drug resistance drug tolerance eco-evolutionary intermittent therapy adaptive therapy continuous therapy Team Medicine intrinsically disordered proteins complex case discussions decision support oncology pathways personalized medicine subspecialty expertise colorectal cancer survivor emergency utilization SARS-CoV-2 care satisfaction pandemic cisplatin non-small cell lung cancer group behavior IDPs phenotype switching mathematical modeling oncolytic virotherapy T-VEC immune checkpoint inhibitors immunotherapy targeted therapy combinational therapy melanoma cutaneous cancers clinical trials neuroendocrine tumors self-assessment NET VITALS implementation science tobacco control smoking cessation cancer prevention lung cancer screening low dose Ct scans LDCT cancer disparities minority health pathways to success renal cell carcinoma gut microbiome translational research EGFR genetic/nongenetic epigenetics oligometastatic prostate cancer metastasis-directed therapy imaging PSMA PET advanced soft tissue sarcoma sarcoma treatment Midwest Sarcoma Trials Partnership multidisciplinary tumor board collaboration endometrial cancer PARP inhibition pathologic complete response Olaparib BRIP1 mutation ATM mutation RAD51C mutation POLE mutation TMB high brain metastases delivery of health care leptomeningeal metastases tumor board integrative oncology clinical care network implementation integration community clinical network phase 1 genomic-driven team medicine precision medicine cancer systems biology clinical network systems biology artificial intelligence City of Hope oncology community practice n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology The previous Special Issue of the Journal of Clinical Medicine, ‘Integrating Clinical and Translational Research Networks—Building Team Medicine’, which highlighted our collective experience from the City of Hope and was published in 2020, was a huge success. Buoyed by the enthusiastic response from our peers and colleagues, we have embarked on bringing out Volume 2. The basic theme is the same—namely, integrating academic medical centers with the clinical network in various geographic locations to ensure that all patients, regardless of their physical proximity to major medical institutions, can benefit from recent clinical advances. As in the previous volume on the importance of including basic research scientists, our aim here is to highlight translational research approaches that leverage the combined knowledge, skills, experience, expertise, and vision of clinicians in academic medical centers, their affiliated community centers, and hospitals, together with those of basic research scientists. However, here we also strive to include bioinformaticians and data scientists. We look forward to sharing our team medicine experience with our colleagues around the world and trust that they will find the approach described in the articles included in this Special issue useful for guiding their approaches for treating cancer patients. 2023-09-11T12:00:43Z 2023-09-11T12:00:43Z 2023 book ONIX_20230911_9783036584720_51 9783036584720 9783036584737 https://directory.doabooks.org/handle/20.500.12854/113918 eng application/octet-stream Attribution 4.0 International https://mdpi.com/books/pdfview/book/7761 https://mdpi.com/books/pdfview/book/7761 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-8473-7 10.3390/books978-3-0365-8473-7 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036584720 9783036584737 230 open access |
| spellingShingle | drug resistance drug tolerance eco-evolutionary intermittent therapy adaptive therapy continuous therapy Team Medicine intrinsically disordered proteins complex case discussions decision support oncology pathways personalized medicine subspecialty expertise colorectal cancer survivor emergency utilization SARS-CoV-2 care satisfaction pandemic cisplatin non-small cell lung cancer group behavior IDPs phenotype switching mathematical modeling oncolytic virotherapy T-VEC immune checkpoint inhibitors immunotherapy targeted therapy combinational therapy melanoma cutaneous cancers clinical trials neuroendocrine tumors self-assessment NET VITALS implementation science tobacco control smoking cessation cancer prevention lung cancer screening low dose Ct scans LDCT cancer disparities minority health pathways to success renal cell carcinoma gut microbiome translational research EGFR genetic/nongenetic epigenetics oligometastatic prostate cancer metastasis-directed therapy imaging PSMA PET advanced soft tissue sarcoma sarcoma treatment Midwest Sarcoma Trials Partnership multidisciplinary tumor board collaboration endometrial cancer PARP inhibition pathologic complete response Olaparib BRIP1 mutation ATM mutation RAD51C mutation POLE mutation TMB high brain metastases delivery of health care leptomeningeal metastases tumor board integrative oncology clinical care network implementation integration community clinical network phase 1 genomic-driven team medicine precision medicine cancer systems biology clinical network systems biology artificial intelligence City of Hope oncology community practice n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2 |
| title | Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2 |
| title_full | Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2 |
| title_fullStr | Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2 |
| title_full_unstemmed | Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2 |
| title_short | Integrating Clinical and Translational Research Networks—Building Team Medicine - Series 2 |
| title_sort | integrating clinical and translational research networks building team medicine series 2 |
| topic | drug resistance drug tolerance eco-evolutionary intermittent therapy adaptive therapy continuous therapy Team Medicine intrinsically disordered proteins complex case discussions decision support oncology pathways personalized medicine subspecialty expertise colorectal cancer survivor emergency utilization SARS-CoV-2 care satisfaction pandemic cisplatin non-small cell lung cancer group behavior IDPs phenotype switching mathematical modeling oncolytic virotherapy T-VEC immune checkpoint inhibitors immunotherapy targeted therapy combinational therapy melanoma cutaneous cancers clinical trials neuroendocrine tumors self-assessment NET VITALS implementation science tobacco control smoking cessation cancer prevention lung cancer screening low dose Ct scans LDCT cancer disparities minority health pathways to success renal cell carcinoma gut microbiome translational research EGFR genetic/nongenetic epigenetics oligometastatic prostate cancer metastasis-directed therapy imaging PSMA PET advanced soft tissue sarcoma sarcoma treatment Midwest Sarcoma Trials Partnership multidisciplinary tumor board collaboration endometrial cancer PARP inhibition pathologic complete response Olaparib BRIP1 mutation ATM mutation RAD51C mutation POLE mutation TMB high brain metastases delivery of health care leptomeningeal metastases tumor board integrative oncology clinical care network implementation integration community clinical network phase 1 genomic-driven team medicine precision medicine cancer systems biology clinical network systems biology artificial intelligence City of Hope oncology community practice n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| topic_facet | drug resistance drug tolerance eco-evolutionary intermittent therapy adaptive therapy continuous therapy Team Medicine intrinsically disordered proteins complex case discussions decision support oncology pathways personalized medicine subspecialty expertise colorectal cancer survivor emergency utilization SARS-CoV-2 care satisfaction pandemic cisplatin non-small cell lung cancer group behavior IDPs phenotype switching mathematical modeling oncolytic virotherapy T-VEC immune checkpoint inhibitors immunotherapy targeted therapy combinational therapy melanoma cutaneous cancers clinical trials neuroendocrine tumors self-assessment NET VITALS implementation science tobacco control smoking cessation cancer prevention lung cancer screening low dose Ct scans LDCT cancer disparities minority health pathways to success renal cell carcinoma gut microbiome translational research EGFR genetic/nongenetic epigenetics oligometastatic prostate cancer metastasis-directed therapy imaging PSMA PET advanced soft tissue sarcoma sarcoma treatment Midwest Sarcoma Trials Partnership multidisciplinary tumor board collaboration endometrial cancer PARP inhibition pathologic complete response Olaparib BRIP1 mutation ATM mutation RAD51C mutation POLE mutation TMB high brain metastases delivery of health care leptomeningeal metastases tumor board integrative oncology clinical care network implementation integration community clinical network phase 1 genomic-driven team medicine precision medicine cancer systems biology clinical network systems biology artificial intelligence City of Hope oncology community practice n/a thema EDItEUR::M Medicine and Nursing thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology |
| url | ONIX_20230911_9783036584720_51 |